These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 26149023)

  • 21. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    ; Shakur H; Roberts I; Bautista R; Caballero J; Coats T; Dewan Y; El-Sayed H; Gogichaishvili T; Gupta S; Herrera J; Hunt B; Iribhogbe P; Izurieta M; Khamis H; Komolafe E; Marrero MA; Mejía-Mantilla J; Miranda J; Morales C; Olaomi O; Olldashi F; Perel P; Peto R; Ramana PV; Ravi RR; Yutthakasemsunt S
    Lancet; 2010 Jul; 376(9734):23-32. PubMed ID: 20554319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tranexamic acid is associated with increased mortality in patients with physiological fibrinolysis.
    Moore HB; Moore EE; Huebner BR; Stettler GR; Nunns GR; Einersen PM; Silliman CC; Sauaia A
    J Surg Res; 2017 Dec; 220():438-443. PubMed ID: 28755903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does Tranexamic Acid Improve Clot Strength in Severely Injured Patients Who Have Elevated Fibrin Degradation Products and Low Fibrinolytic Activity, Measured by Thrombelastography?
    Moore HB; Moore EE; Chapman MP; Hansen KC; Cohen MJ; Pieracci FM; Chandler J; Sauaia A
    J Am Coll Surg; 2019 Jul; 229(1):92-101. PubMed ID: 30936005
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Avoidable mortality from giving tranexamic acid to bleeding trauma patients: an estimation based on WHO mortality data, a systematic literature review and data from the CRASH-2 trial.
    Ker K; Kiriya J; Perel P; Edwards P; Shakur H; Roberts I
    BMC Emerg Med; 2012 Mar; 12():3. PubMed ID: 22380715
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antifibrinolytic drugs for treating primary postpartum haemorrhage.
    Shakur H; Beaumont D; Pavord S; Gayet-Ageron A; Ker K; Mousa HA
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD012964. PubMed ID: 29462500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CRASH-3 - tranexamic acid for the treatment of significant traumatic brain injury: study protocol for an international randomized, double-blind, placebo-controlled trial.
    Dewan Y; Komolafe EO; Mejía-Mantilla JH; Perel P; Roberts I; Shakur H;
    Trials; 2012 Jun; 13():87. PubMed ID: 22721545
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tranexamic acid in pediatric hemorrhagic trauma.
    Borgman MA; Nishijima DK
    J Trauma Acute Care Surg; 2023 Jan; 94(1S Suppl 1):S36-S40. PubMed ID: 36044459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tranexamic acid for trauma patients: a critical review of the literature.
    Cap AP; Baer DG; Orman JA; Aden J; Ryan K; Blackbourne LH
    J Trauma; 2011 Jul; 71(1 Suppl):S9-14. PubMed ID: 21795884
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of tranexamic acid in major trauma: a sex-disaggregated analysis of the Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage (CRASH-2 and CRASH-3) trials and UK trauma registry (Trauma and Audit Research Network) data.
    Nutbeam T; Roberts I; Weekes L; Shakur-Still H; Brenner A; Ageron FX
    Br J Anaesth; 2022 Aug; 129(2):191-199. PubMed ID: 35597623
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of prehospital TXA on mortality among bleeding trauma patients: A systematic review and meta-analysis.
    Almuwallad A; Cole E; Ross J; Perkins Z; Davenport R
    J Trauma Acute Care Surg; 2021 May; 90(5):901-907. PubMed ID: 33605702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CRASH-2 (Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage) intracranial bleeding study: the effect of tranexamic acid in traumatic brain injury--a nested randomised, placebo-controlled trial.
    Perel P; Al-Shahi Salman R; Kawahara T; Morris Z; Prieto-Merino D; Roberts I; Sandercock P; Shakur H; Wardlaw J
    Health Technol Assess; 2012; 16(13):iii-xii, 1-54. PubMed ID: 22417901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased risk of fibrinolysis shutdown among severely injured trauma patients receiving tranexamic acid.
    Meizoso JP; Dudaryk R; Mulder MB; Ray JJ; Karcutskie CA; Eidelson SA; Namias N; Schulman CI; Proctor KG
    J Trauma Acute Care Surg; 2018 Mar; 84(3):426-432. PubMed ID: 29298240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of intramuscular tranexamic acid in bleeding trauma patients: a clinical trial.
    Grassin-Delyle S; Shakur-Still H; Picetti R; Frimley L; Jarman H; Davenport R; McGuinness W; Moss P; Pott J; Tai N; Lamy E; Urien S; Prowse D; Thayne A; Gilliam C; Pynn H; Roberts I
    Br J Anaesth; 2021 Jan; 126(1):201-209. PubMed ID: 33010927
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is Tranexamic Acid Associated With Mortality or Multiple Organ Failure Following Severe Injury?
    Richards JE; Fedeles BT; Chow JH; Morrison JJ; Renner C; Trinh AT; Schlee CS; Koerner K; Grissom TE; Betzold RD; Scalea TM; Kozar RA
    Shock; 2021 Jan; 55(1):55-60. PubMed ID: 33337787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Guidance Document for the Prehospital Use of Tranexamic Acid in Injured Patients.
    Fischer PE; Bulger EM; Perina DG; Delbridge TR; Gestring ML; Fallat ME; Shatz DV; Doucet J; Levy M; Stuke L; Zietlow SP; Goodloe JM; VanderKolk WE; Fox AD; Sanddal ND
    Prehosp Emerg Care; 2016; 20(5):557-9. PubMed ID: 26985786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tranexamic acid administration to pediatric trauma patients in a combat setting: the pediatric trauma and tranexamic acid study (PED-TRAX).
    Eckert MJ; Wertin TM; Tyner SD; Nelson DW; Izenberg S; Martin MJ
    J Trauma Acute Care Surg; 2014 Dec; 77(6):852-8; discussion 858. PubMed ID: 25423534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Implementation of tranexamic acid for bleeding trauma patients: a longitudinal and cross-sectional study.
    Coats TJ; Fragoso-Iñiguez M; Roberts I
    Emerg Med J; 2019 Feb; 36(2):78-81. PubMed ID: 30530744
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of Military Use of Tranexamic Acid and Associated Thromboembolic Events.
    Johnston LR; Rodriguez CJ; Elster EA; Bradley MJ
    JAMA Surg; 2018 Feb; 153(2):169-175. PubMed ID: 29071337
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tranexamic acid use in severely injured civilian patients and the effects on outcomes: a prospective cohort study.
    Cole E; Davenport R; Willett K; Brohi K
    Ann Surg; 2015 Feb; 261(2):390-4. PubMed ID: 25412319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of tranexamic acid in trauma patients: A retrospective quantitative analysis.
    Ng M; Perrott J; Burgess S
    Am J Emerg Med; 2019 Mar; 37(3):444-449. PubMed ID: 29903672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.